Fairfax, Va. (PRWEB) July 8, 2009 PharmSource Information Services, Inc., a respected provider of business intelligence on contract drug development and manufacture, is pleased to announce the publication of a new white paper – “The U.S. Foreign Corrupt Practices Act (FCPA): How to Minimize Your Risk.” This incisive resource provides guidelines on how [...]

Continue reading " PharmSource Releases White Paper on Role of U.S. Foreign Corrupt Practices Act (FCPA) in the Bio/Pharma Industry "